|
Volumn 107, Issue 4 Suppl 2, 2007, Pages
|
The endocannabinoid system as a novel approach for managing obesity.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANNABINOID 1 RECEPTOR;
ENDOCANNABINOID;
PIPERIDINE DERIVATIVE;
PYRAZOLE DERIVATIVE;
RIMONABANT;
ABDOMINAL FAT;
CARDIOVASCULAR DISEASE;
CONTROLLED CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG EFFECT;
ENERGY METABOLISM;
HOMEOSTASIS;
HUMAN;
METABOLISM;
OBESITY;
REVIEW;
RISK FACTOR;
ABDOMINAL FAT;
CARDIOVASCULAR DISEASES;
CONTROLLED CLINICAL TRIALS;
ENDOCANNABINOIDS;
ENERGY METABOLISM;
HOMEOSTASIS;
HUMANS;
OBESITY;
PIPERIDINES;
PYRAZOLES;
RECEPTOR, CANNABINOID, CB1;
RISK FACTORS;
|
EID: 35449002509
PISSN: 00986151
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (25)
|